Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rapid test for tuberculosis (TB) proves 100% accurate:

This article was originally published in Clinica

Executive Summary

ID Biomedical's rapid culture confirmation test for mycobacterium tuberculosis consistently distinguished the bacterium from other species in tests at the University of Arkansas for Medical Sciences. The university is developing the test with ID Biomedical which uses the company's gene detection platform called Cycling Probe Technology. The company plans to complete development of the test at its site in British Columbia and begin clinical trials in the fourth quarter of 1998.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT080501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel